The FDA announced on Nov. 8, 2012, that Hospira Inc. is recalling Carboplatin Injection vials due to crystallization hazards. The agency classified the Class I recall as completed.
How to tell if you have it
- Brand: Hospira
- Product: Carboplatin Injection Vials
- NDC 61703-339-50 (Hospira label)
- NDC 61703-360-50 (Novaplus label)
- Lots Z011711AA (Hospira label) and Z011711AB (Novaplus label)
- Expiration: 08/2013
- Quantity: 31,326 vials
The hazard
The product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Par Health Recalls Buprenorphine Injections Due to Crystallization (Sept. 8, 2026) and American Regent Papaverine HCl Injection Recall: Particulate Matter Hazard (July 24, 2026).